Whether or not VEGF121b activates VEGFR-2 in a similar way is yet to be investigated, as are the potential effects of simultaneous VEGF121b and VEGF165b administration of receptor activity, angiogenesis or tumour growth. Here, KDR is linked to neoplasm.